Genentech

HERCEPTIN

  1. Home
  2.  / 
  3. J Code
  4.  / HERCEPTIN – J9355

Manufacturer:

Genentech

Name:

HERCEPTIN

HCPCS Code Descriptor:

Injection, trastuzumab, excludes biosimilar, 10 mg

Category:

J Code

HCPCS:

J9355

NDC(s):

50242-0132-01, 50242-0132-10

Primary Type:

Oncology

Generic Status:

Single-Source

Route of Administration:

Intravenous

About:

HERCEPTIN is an Oncology drug manufactured by Genentech and administered via the Intravenous route of administration. The J Code: J9355 is aligned to the drug HERCEPTIN.

Access Pricing and More By Registering

HCPCS Added Date:

1/1/00

HCPCS Effective Date:

7/1/19

HCPCS Short Description:

Inj trastuzumab excl biosimi

Billing and Coding Guide:

https://www.genentech-access.com/content/dam/gene/accesssolutions/pdfs/coding/Herceptin-Billing-Coding-for-Metastatic-Gastric-Cancer.pdf, https://www.genentech-access.com/content/dam/gene/accesssolutions/pdfs/coding/Herceptin-Billing-Coding-for-FL-SL-TL-Metastatic-Breast-Cancer.pdf

Patient Assistance:

https://www.gene.com/patients/patient-foundation

HERCEPTIN - J9355